All Industries

Top Biotech Companies

3,138 Biotech companies, sorted by total funding raised.

LifeMine Therapeutics

Clinical-stage biopharma mining fungal genomes to discover genetically-encoded small molecules fo...

Cambridge, United States51–200Biotech, Drug Discovery
Venture Unknown·$300.0M·Jan 2025
GondolaBio

Biopharmaceutical company focusing on pre-clinical and early-stage clinical programs for genetic ...

United StatesBiotech, Healthcare
Series A·$300.0M·Aug 2024
Radius HealthAcquired

Commercial-stage biopharmaceutical company focused on bone health and related therapeutic areas.

United StatesBiotech, Healthcare
Series E·$298.0M·Apr 2013
Soley Therapeutics

Biotechnology company developing next-generation therapeutics for serious diseases

South San Francisco, United States11–50Artificial Intelligence, Biotech
Series C·$295.0M·Jan 2026
Harmony BiosciencesIPO

Commercial-stage pharmaceutical company focused on developing and commercializing innovative ther...

Plymouth Meeting, United States201–500healthtech, Biotech
Venture Unknown·$295.0M·Jan 2018
Octant Bio

Small molecule correctors for protein misfolding, enabled by a synthetic biology, high throughput...

Los Angeles, United States51–200Healthcare, Biotech
Series C·$289.9M·Oct 2025
The EVERY Company

Creating Vital Ingredients For The World

Daly City, United States51–200Biotech, Food Tech
Series D·$289.8M·Oct 2025
Repertoire Immune Medicines

Repertoire Immune Medicines is a clinical-stage biotechnology company decoding the human T cell r...

Cambridge, United States51–200Biotech
Venture Unknown·$289.0M·Apr 2025
Emalex

Emalex Biosciences develops new treatments for central nervous system disorders, including a late...

Chicago, United States11–50Biotech, Healthcare
Series D·$285.0M·Nov 2022
AbSciIPO

Generative AI drug creation platform for designing and developing biologics

Vancouver, United States201–500Artificial Intelligence, Biotech
Growth Equity·$279.5M·Aug 2025
Nuvation Bio Inc.IPO

Global oncology company focused on developing therapies to tackle the toughest challenges in canc...

New York, United States51–200healthtech, biotech
Series A·$275.0M·Oct 2019
Trivascular

Developing endovascular repair devices to treat abdominal aortic aneurysms

Santa Rosa, United States201–500Biotech, Medical Devices
Series E·$267.8M·Nov 2013
Tectonic TherapeuticIPO

Clinical-stage biotechnology company focused on the discovery and development of therapeutic prot...

Watertown, United States51–200healthtech, Biotech
Private Equity·$265.0M·Feb 2025
AbbiskoIPO

Shanghai-based oncology biotech discovering precision and immuno-oncology therapeutics for cancer...

Shanghai, China201–500Biotech, Oncology
Series D·$263.0M·Jan 2021
Mammoth Biosciences

CRISPR platform company building next-generation gene editing therapeutics and molecular diagnost...

Brisbane, United States51–200Biotech
Series D·$263.0M·Sep 2021
V
VeradermicsIPO

Late clinical-stage biopharmaceutical company developing therapies for common dermatologic condit...

United StatesBiotech, Healthcare
Series C·$262.2M·Oct 2025
F2G

Clinical-stage biopharmaceutical company developing novel antifungal therapies for rare, life-thr...

Manchester, United Kingdom51–200Biotech, Healthcare
Venture Unknown·$261.0M·Sep 2024
Kronos BioClosed

Clinical-stage biopharma developing small‑molecule therapeutics targeting deregulated transcripti...

San Mateo, United States1–10Biotech, Healthcare
Series B·$260.0M·Aug 2020
NewLimit

Longevity biotech developing epigenetic reprogramming medicines to extend human healthspan and re...

South San Francisco, United States11–50Biotech, Healthcare
Corporate Round·$260.0M·Oct 2025
Lyndra Therapeutics, Inc.

R&D company with 4 SBIR/STTR awards from Department of Health and Human Services.

Watertown, United States51–200Biotech, Healthcare
Series E·$259.8M·Dec 2023
Alamar Biosciences

Precision proteomics company providing automated, ultra-high sensitivity protein analysis platfor...

Fremont51–200Biotech, Diagnostics
Convertible·$258.0M·Jan 2026
WILSON WOLF MANUFACTURING CORPORATION

R&D company with 2 SBIR/STTR awards from Department of Health and Human Services.

NEW BRIGHTON, United States11–50Biotech, Healthcare
Venture Unknown·$257.0M·Mar 2023
Genesis Therapeutics

Genesis Therapeutics is an AI drug discovery company using generative AI and physics-based molecu...

Burlingame51–200Artificial Intelligence, Biotech
Series B·$256.1M·Aug 2023
Frontier Medicines

Clinical-stage precision-medicine biotech using chemoproteomics and AI to discover covalent small...

San Francisco, United States51–200Biotech, Drug Discovery
Extension Round·$255.5M·Jun 2024
Boundless BioIPO

Clinical-stage precision oncology company developing ecDNA-directed therapies targeting extrachro...

San Diego, United States11–50Biotech, Healthcare
Series C·$251.4M·May 2023